Clinical Trials Directory

Trials / Completed

CompletedNCT00497913

Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
52 (estimated)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether a single injection of Dysport with a new protocol at forearm is effective in the management of chronic lateral epicondylitis.

Detailed description

Some studies valued the effectiveness of botulinum toxin. There is a great amount of controversy on the amount of botulinum toxin injected and the location of the injection. The purpose of the study is to compare the effectiveness of botulinum toxin injection with placebo at a new injection site at the forearm in the treatment of chronic tennis elbow unrelieved by corticosteroid injection and physiotherapy. It is a double blind randomized controlled trial.

Conditions

Interventions

TypeNameDescription
DRUGNaCl 0.9%
DRUGBotulinum Toxin A

Timeline

Start date
2007-08-01
Primary completion
2008-03-01
Completion
2008-04-01
First posted
2007-07-09
Last updated
2008-04-23

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT00497913. Inclusion in this directory is not an endorsement.